Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Davion HealthCare

Request full access

Non-invasive home tests for early medical anomaly detection.

Cork, IrelandHealth Tech & Medtech

About Davion HealthCare

Davion HealthCare Plc is a medical technology company that develops and commercializes non-invasive, at-home diagnostic tests for the early detection of various health anomalies, including those associated with cancers. The company was incorporated in Cyprus on November 29, 2022, and later redomiciled its corporate headquarters to Cork, Ireland, in September 2024 to align better with its core markets in the European Union and the United States. The leadership team includes Chief Executive Officer Jack Kaye and Non-Executive Chairman Sir Eric Peacock. Davion's business model has recently evolved from a capital-light, licensing-led model to a direct commercialization strategy. Previously, the company focused on designing and patenting medical products and then licensing the manufacturing, marketing, and distribution rights to partners. In June 2026, Davion terminated its existing global licensing arrangements for its flagship product to gain greater control over its product strategy and customer relationships. This strategic shift includes acquiring controlling interests in distribution companies like Solar Medical and Chemical Limited to establish its own commercial platform, initially in the United Kingdom. The company also continues to build its portfolio through strategic acquisitions, such as the proposed purchase of Humaskan Ltd, a medical technology company with proprietary intellectual property. The company's product pipeline features four non-invasive, remote health monitoring solutions that have met Class I regulatory standards in the US (FDA), Europe (CE), and the UK (UKCA). Its lead product, BreastCheck™, is an FDA-registered, at-home screening test that uses thermography to detect temperature variations in breast tissue, which can indicate potential anomalies. Other products in development include FootFlow, a test for diabetics to monitor blood flow in the extremities; Testic, for detecting testicular anomalies; and ThermaDerm, which monitors skin temperature across the body. These products are designed as early-warning systems, empowering individuals to monitor their health proactively from home and reducing the strain on healthcare systems. The company is in the process of a proposed direct listing on the Nasdaq Global Market under the ticker symbol "DAVI".

Source: Dealroom company data

At a glance

Status
Listed
Headquarters
Cork, Ireland
Listing
IPO 2026
Open positions
None listed
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Oncology, medical testing, Non-Invasive medical devices and treatments
Business model
Manufacturing
Client focus
B2B
Investment activity
1 company
Capital deployed
—
Preferred round
Unknown
Links
Website

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
IPO✓Exit Oct 2026 $0 $306M Undisclosed ↗
POST IPO DEBT✓Debt Aug 2026 $40M — Undisclosed ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Davion HealthCare website traffic

Latest recorded traffic for Davion HealthCare is 90 monthly website visits, down 66.7% over the last three months.

Latest monthly visits90 3-month web change-66.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Davion HealthCare in the Cork ecosystem

Live from Dealroom

The Davion HealthCare office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇮🇪 Ireland · Cork HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Davion HealthCare on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Davion HealthCare’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.